Emosis

Emosis is a medical diagnostic company specializing in the field of hemostasis and thrombosis. The company develops and commercializes innovative in vitro diagnostic (IVD) tests designed to improve the management of patients with complex coagulation disorders. Their primary focus is on providing rapid, reliable assays for Heparin-Induced Thrombocytopenia (HIT) and monitoring the efficacy of antiplatelet therapies. By utilizing advanced flow cytometry techniques, Emosis aims to reduce the risk of thrombotic complications and optimize patient care in critical settings. The company's technology platform allows for the precise measurement of platelet activation, offering a more comprehensive view of a patient's thrombotic risk than traditional plasma-based tests.